Cancer Research Institute

Funds and coordinates laboratory and clinical research on the immune system and its role in the control of cancer.

Designers please log in to view

The Cancer Immunotherapy Consortium, a program of the nonprofit Cancer Research Institute, is an association of 70+ academic institutions and companies from the pharmaceutical and biotechnology industries that convenes stakeholders in cancer vaccine and cancer immunotherapy development to discuss the latest advances in development of immune-based cancer therapies and to overcome obstacles to development. Membership in the Consortium provides stakeholders several benefits, including access to industry-leading news, interface with regulatory agency representatives, collaboration opportunities, contribution to position papers addressing important topics in the field, association with the Cancer Research Institute, and opportunities to present data to other field leaders at our annual meetings and conferences.